Stimulus dimension shifts in patients with schizophrenia, with and without paranoid hallucinatory symptoms, or obsessive compulsive disorder: strategies, blocking and monoamine status.
Reversal, and intra-dimensional (ID) and extra-dimensional (ED) nonreversal discrimination shifts were studied to see if learned inattention to the irrelevant dimension differentially influenced the efficacy of learning and stimulus choice strategy. Performance was compared with conditioned blocking (CB) and monoamine metabolic status between healthy controls, patients with obsessive compulsive disorder (OCD) or schizophrenia with (PH) or without (NP) active paranoid hallucinatory symptoms. PH and NP patients improved learning with practice, but showed an impaired shift on each task. OCD patients were impaired only on the ED-shift. The NP patient's impairment was nonspecific and, unlike PH and controls, it related to reversal performance. All subjects acquired an attentional set for colour reflected in the length of stimulus-response sequences. Analysis of paired-stimulus choice-strategies showed that while all patients showed fewer correct win-stay choices, only PH patients perseverated with lose-stay choices. Learning about the added stimulus in the CB task related to ID-shift efficiency in NP patients. Increases of dopamine activity related to delayed learning but more switches of stimulus choice in the shift-tasks. Increases of serotonin activity correlated with faster learning in controls, OCD and PH patients. In NP patients the opposite held for dopamine and serotonin activity. Thus the two learned inattention tasks have different if related requirements and correlates: the data are consistent with the use of automatic exogenous attention strategies by NP patients, of inefficient controlled attention by PH patients and the automatization of endogenous processes in controls.
Oades
R D
RD
Biological Psychiatry Group, University Clinic for Child and Adolescent Psychiatry, Essen, Germany. oades@uni-essen.de
D000293:Adolescent; D000328:Adult; D015306:Biogenic Monoamines / Q000378:metabolism*; D004192:Discrimination, Psychological / Q000502:physiology; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000378:metabolism / Q000523:psychology*; D011569:Psychiatric Status Rating Scales; D011597:Psychomotor Performance / Q000502:physiology; D011930:Reaction Time / Q000502:physiology; D012563:Schizophrenia, Paranoid / Q000378:metabolism / Q000523:psychology*; D012565:Schizophrenic Psychology; D012701:Serotonin / Q000378:metabolism
D015306:Biogenic Monoamines; D012701:Serotonin; D004298:Dopamine